67
Views
5
CrossRef citations to date
0
Altmetric
Case Series

Perioperative management of hemophilia patients receiving total hip and knee arthroplasty: a complication report of two cases

, , , , , , & show all
Pages 1383-1389 | Published online: 15 Sep 2015

Figures & data

Figure 1 Anteroposterior hip radiographs of case 1 (31-year-old male with severe hemophilia).

Note: (A) Before and (B) after total hip arthroplasty.
Figure 1 Anteroposterior hip radiographs of case 1 (31-year-old male with severe hemophilia).

Figure 2 Perioperative management of clotting factor VIII (Kogenate FS) for case 1.

Notes: (A) Bolus doses of factor VIII on preoperative days (PrODs); (B) continuous infusion of factor VIII on postoperative days (PODs); (C) postoperative trough factor VIII levels.
Figure 2 Perioperative management of clotting factor VIII (Kogenate FS) for case 1.

Figure 3 Photographs of hematoma in case 1 (31-year male with severe hemophilia A).

Notes: (A) Intraoperative view of 300 g hematoma filled in the intra-articular cavity; (B) the hematoma after surgical removal.
Figure 3 Photographs of hematoma in case 1 (31-year male with severe hemophilia A).

Figure 4 Anteroposterior and lateral knee radiographs of case 2 (46-year-old male).

Note: (A, B) Before and (C, D) after total knee arthroplasty.
Figure 4 Anteroposterior and lateral knee radiographs of case 2 (46-year-old male).

Figure 5 Intraoperative view of hematoma connecting to the distal subcutaneous area (white arrow) in case 2 (46-year-old male).

Figure 5 Intraoperative view of hematoma connecting to the distal subcutaneous area (white arrow) in case 2 (46-year-old male).

Figure 6 Perioperative management of clotting factor VIII (Advate) for case 2.

Notes: (A) Bolus doses of factor VIII on preoperative days (PrODs); (B) continuous infusion of factor VIII on postoperative days (PODs); (C) postoperative trough factor VIII levels.
Figure 6 Perioperative management of clotting factor VIII (Advate) for case 2.